Sterling Investment Counsel, LLC 9 Meters Biopharma, Inc. Transaction History

Sterling Investment Counsel, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$0.26 - $0.64 $4,558 - $11,221	-17,533 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$0.52 - $1.0 $2,600 - $5,000	5,000 Added 39.89%	17,533 $11,000
Q4 2021 Apr 29, 2022	BUY	$0.85 - $1.33 $10,653 - $16,668	12,533 New	12,533 $12,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Sterling Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Sterling Investment Counsel, LLC with notifications on news.